EX VIVO CORNEAL CROSS-LINKING FOR VASCULARIZED HIGH-RISK KERATOPLASTY (EXCROSSV)

$2,553,092FY2024Defense Health AgencyDOD

Massachusetts Eye And Ear Infirmary, Boston MA

Investigators